HMGB1 as a Late Mediator of Lethal Systemic Inflammation
Top Cited Papers
- 15 November 2001
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 164 (10), 1768-1773
- https://doi.org/10.1164/ajrccm.164.10.2106117
Abstract
No abstract availableThis publication has 72 references indexed in Scilit:
- Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motilityMatrix Biology, 2000
- Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling PathwaysJournal of Biological Chemistry, 1999
- Another negative clinical trial of a new agent for the treatment of sepsisCritical Care Medicine, 1995
- Interaction between Cisplatin-modified DNA and the HMG Boxes of HMG 1: DNase I Footprinting and Circular DichroismJournal of Molecular Biology, 1995
- Stimulation of Transcription in Cultured Cells by High Mobility Group Protein 1: Essential Role of the Acidic Carboxyl-Terminal RegionBiochemistry, 1994
- Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia.The Journal of Experimental Medicine, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic ShockThe Journal of Infectious Diseases, 1990
- Recombinant Interleukin 1 and Tumor Necrosis Factor Acting in Synergy to Release Thromboxane, 6-KETO-PGF1α, and PGEI2, by Human NeutrophilsScandinavian Journal of Rheumatology, 1988